About NeuroPace, Inc. 
NeuroPace, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 23 Schemes (13.6%)
Foreign Institutions
Held by 31 Foreign Institutions (35.31%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
24 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
Pharmaceuticals & Biotechnology
USD 321 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.08
-131.22%
16.53






